PixarBio Corporation announced that Steven J. Chartier resigned from his position as Chief Operating Officer effective February 2, 2017. In connection with Mr. Chartier's resignation, Chrystal Lucia has been promoted to the position of Director of Regulatory Affairs, responsible for U.S. FDA engagement and contract manufacturing. Chris Doherty has been promoted to Associate Director of Regulatory Affairs, responsible for clinical studies.